S. Ferro

Campylobacter jejuni infection occurring during pregnancy

A. Simor, S. Ferro, 1990, European Journal of Clinical Microbiology and Infectious Diseases.

HIV infection in patients over 55 years of age.

I. Salit, S. Ferro, 1992, Journal of acquired immune deficiency syndromes.

Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.

K. Marsh, C. Loucq, R. Sauerwein, 2009, Vaccine.

Correlation between Vancomycin MIC Values and Those of Other Agents against Gram-Positive Bacteria among Patients with Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus

K. Stellrecht, S. Harrington, M. Bonafede, 2009, Antimicrobial Agents and Chemotherapy.

Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations.

S. Ferro, A. Capriles-Hulett, E. Rodriguez, 2008, Allergologia et immunopathologia.

Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults.

J. Langley, F. Noya, S. Halperin, 2007, Vaccine.

Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age.

R. Gold, E. Mills, S. Ferro, 2007, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries.

D. Briles, S. Hollingshead, L. Baril, 2006, Journal of medical microbiology.

Comparative antifungal activity of cilofungin (LY121019) against Candida species, including evaluation of susceptibility testing method.

Jasper Hii, D. Low, D. Hoban, 1992, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori

D. Low, A. Simor, S. Ferro, 1989, Antimicrobial Agents and Chemotherapy.